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ABSTRACT
Simian Virus 40 (SV40) large T antigen (T Ag) is a
multifunctional viral oncoprotein that regulates
viral and cellular transcriptional activity. However,
the mechanisms by which such regulation occurs
remain unclear. Here we show that T antigen
represses CBP-mediated transcriptional activity.
This repression is concomitant with histone H3
deacetylation and is TSA sensitive. Moreover,
our results demonstrate that T antigen interacts
with HDAC1 in vitro in an Rb-independent manner.
In addition, the overexpression of HDAC1 coop-
erates with T antigen to antagonize CBP transacti-
vation function and correlates with chromatin
deacetylation of the TK promoter. Finally, decreas-
ing HDAC1 levels with small interfering RNA (siRNA)
partially abolishes T antigen-induced repression.
These findings highlight the importance of the
histone acetylation/deacetylation balance in the
cellular transformation mediated by oncoviral
proteins.
INTRODUCTION
Simian virus 40 (SV40) large T antigen (T Ag) is a
708-amino-acid multifunctional oncoviral protein
involved in numerous viral and cellular processes,
including viral replication, transcriptional activation and
repression, and blockade of diﬀerentiation and cell
transformation (1). T antigen can be post-translationally
modiﬁed by phosphorylation, glycosylation, adenylation
and ADP ribosylation. Moreover, T antigen can be
acetylated by CBP in a p53-dependent manner (2),
although the functional consequences of this modiﬁcation
remain largely unknown. The ability of T Ag to transform
cells depends on complex interactions between viral
oncoproteins and the various intracellular proteins
involved in cell control (3) and transcription regulation,
such as p53 (4,5), pRb and the Rb-related proteins p107
and p130 (6–9) and CBP/p300 (10–13). T antigen requires
the LXCXE motif to interact with the pRb protein family.
Two regions in the C-terminal part of the T antigen
protein are required for p53 binding. Finally, the regions
of T antigen required for CBP/p300 interaction overlap
these p53-binding regions. Other oncoviral proteins, such
as E1A, also require CBP/p300 and p53 targeting for cell
transformation.
Histone acetylation at the N-terminal tails is a regulatory
mechanism that controls gene expression (14,15). Histone
acetylation levels inside cells are maintained through the
coordinated action of histone acetyltransferases (HATs)
and deacetylases (HDACs). CBP/p300, a coactivator
protein (16) involved in both proliferative and diﬀerentiat-
ing pathways, contains HAT activity (17,18). CBP/p300 is
ubiquitously expressed and regulates a broad spectrum of
biological activities such as proliferation, diﬀerentiation,
cell cycle control and apoptosis. To accomplish such
processes, CBP/p300 must be recruited to a speciﬁc
promoter via interactions with a sequence-speciﬁc tran-
scription factor, including CREB, c-Myb, MyoD, E2F1,
p53, nuclear hormone receptors, etc.
In mammalian cells, HDAC1 and HDAC2 are found in
multiprotein complexes. These have been implicated as
corepressors that associate with diﬀerent factors such as
Rb, Mad, MeCP2, etc., in repressing transcription.
Several reports have shown that viral oncoproteins
select HAT enzymes as cellular partners, in some cases
disrupting enzymatic activity. E1A can increase, decrease
or redirect CBP/p300 HAT activity (19–21); while CBP,
by interacting with T antigen increases its HAT activity
(22). In addition, CBP, p300 and P/CAF acetylate several
viral oncoproteins such as AdE1A (23,24) and T antigen
(2), although the consequences of these modiﬁcations
remain to be elucidated. Oncoviral proteins also target
HDAC complexes: the adenovirus E1B-55K protein
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(25); HIV Tat displaces HDAC1, which is bound to
SATB1, leading to increased acetylation of promoters
in vivo (26); the Epstein-barr virus nuclear antigen 3C
interacts with HDAC1 to repress transcription (27);
the E7 oncoprotein from papilloma virus type 16
(HPV16) interacts with HDAC activity, resulting in
the stimulation of cell growth (28).
T antigen aﬀects transcription levels of the cAMP-
responsive promoter, which is modulated in vivo by p300
in REV2 cells. Moreover, by interacting with CBP/p300, T
antigen abrogates CBP/p300-mediated transcriptional
activity (11,12), although the mechanism involved remains
unclear. Here we examine the mechanisms underlying
the repressive behavior of T antigen. Our results not
only show that T antigen repression is alleviated by
increasing cellular acetylation levels via trichostatin
A (TSA) treatment, but also that it acts concomitantly
with histone H3 deacetylation. Moreover, we have
demonstrated that T antigen interacts in vitro with
HDAC1 in an Rb-independent manner. The data pre-
sented in this study link chromatin modiﬁcation to
T antigen transcriptional regulatory potential.
MATERIALS AND METHODS
Constructs
PSG5-T antigen, PSG5-T antigen K1 and PSG5-T antigen
PVU-1 plasmids were kindly provided by Dr J. DeCaprio.
pcDNA3Gal4-HAT-CBP2, pcDNA3Gal4-HAT,
pcDNA3Gal4-CBP (FL) and pcDNA3-HDAC1-Flag
constructs have been previously described (29) and were
kindly provided by Dr T. Kouzarides. The Gal4-TK-
luciferase and Gal4-hsp70-bgal reporters were supplied by
Dr J. Bernues. The pSUPER-Control-siRNA was kindly
provided by Dr E. Martı´.
Cell cultures,transfections and reporter gene assays
HeLa, CV1 and CV1COS cells were maintained in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) with
10% foetal calf serum (FCS) and grown at 378C, 5%
CO2. Cells were transfected by a standard calcium
phosphate coprecipitation (for luciferase and b galactosi-
dase assays) or with a Jet-PEI Kit (Polyplus-Transfection,
Illkirch, France) (for ChIPs and siRNA assays) with
0.1–2mg (as indicated) of either expression vector and with
2mg reporter plasmid. The cells were then washed in PBS
after 14h and harvested 36h after transfection (except
when indicated). They were subsequently washed once in
phosphate-buﬀered saline (PBS). Luciferase and
b galactosidase assays were performed using a ‘Promega
Dual Kit’ and a ‘Promega Galactosidase Kit’ respectively,
following the manufacturer’s instructions. The TSA
treatment was conducted at 100nM for 18h.
Cell extractpreparation and proteincontent estimation
Total cell extracts were prepared as follows: cells were
lysed in 1ml of buﬀer A (50mM Tris, pH 8, 150mM
NaCl, 0.5% NP40, 10mg/ml of aprotinin and leupeptin,
1mM phenylmethylsulfonyl ﬂuoride, 50mM NaF and
10mM Na2-B-glycerophosphate) by maintaining the cells
for 20min on ice; cell debris were removed by centrifuga-
tion at 12000 g for 10min at 48C. Protein content was
measured by using the ‘BIO-RAD protein assay reagent’
following the manufacturer’s instructions.
Chromatin immunoprecipitation analysis (ChIPs)
HeLa cells were treated with 1% formaldehyde at room
temperature for 15min. The reaction was stopped by the
addition of glycine to a ﬁnal concentration of 125mM.
Cells were washed once in ice-cold PBS, once in
buﬀer I (0.25% triton X-100, 10mM EDTA, 0.5mM
EGTA, 10mM Hepes pH 6.5) and in buﬀer II (200mM
NaCl, 1mM EDTA, 0.5mM EGTA, 10mM Hepes pH
6.5) at 48C for 10min. The pellet was then resuspended
in lysis buﬀer (1% SDS, 10mM EDTA, 50mM Tris pH
8.1mg/ml protease inhibitors, 1mM PMSF) and sonicated
on ice until the cross-linked chromatin was sheared to
an average DNA fragment length of 0.2–0.5kbp. After
centrifugation (10–45min 12000 g) soluble cross-linked
chromatin was diluted 1:10 in immunoprecipitation (IP)
buﬀer (1% triton X-100, 2mM EDTA, 150mM NaCl,
20mM Tris pH 8 and protease inhibitors), divided into
aliquots and stored at  808C. Chromatin preparations
were pre-cleared by incubation with Protein A-Sepharose
solution: 30mg pre-immune serum (35mg/ml), 2mg herring
sperm DNA (1mg/ml), 50ml Protein A-Sepharose CL4B
(Amersham-Pharmacia) 10% in TE buﬀer (50mg/500ml
TE) in IP buﬀer for 2h at 48C under rotation. The protein
A-Sepharose was removed by centrifugation; the pre-
cleared chromatin was immunoprecipitated by incubation
with the antibody O/N at 48C. The immunoprecipitates
were washed in buﬀers TSE I (0.1% SDS, 1% Triton
X-100, 2 Mm EDTA, 20mM Tris-HCl pH 8, 150mM
NaCl), TSE II (0.1% SDS, 1% Triton X-100, 2 Mm
EDTA, 20mM Tris-HCl pH 8, 500mM NaCl), buﬀer III
(0.25M LiCl, 1% NP40, 1% Deoxycholate, 1mM EDTA,
10mM Tris-HC l pH 8), and three times with Tris-EDTA
(TE) buﬀer. Washed pellets were eluted in 300mlo f
a solution containing 1% SDS, 0.1M NaHCO3. Eluted
pellets were de-cross-linked O/N at 658C, and then
puriﬁed in 50ml TE buﬀer using a DNA puriﬁcation
kit (Amersham-Pharmacia). The DNA was analyzed
by PCR. The antibodies used were as follows: rabbit
polyclonal antibody against Acetyl H3 (k9, k14) and
Poly-acetyl H4 (K5, K8, K12, K16) (Upstate) and
HDAC1 (Abcam).
PCR analysis
PCR analysis was performed as described by Breiling and
colleagues (30). PCR products measured 220–330bp and
were resolved by agarose-gel electrophoresis and
revealed by staining with ethidium bromide. Decreasing
amounts of input DNA (10, 1, 0.1 and 0.01%) were used
to determine the linear range of the PCR reactions
for each primer pair and IP. The following primer
pairs were used: 50CATGTCGATCCGCTCGG-30 and
50-CTTTATGTTTTTGGCGTCTTCCA-30, for TK-luc
promoter and 50CCCCAAAGGTTGCCTGGCGG-30
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b-receptor promoter, provided by TIB MOLBIOL
(Germany).
ChIP quantification
PCR gel bands were quantiﬁed with QuantityOne
software (Bio-Rad). Values from immunoprecipitated
samples were subsequently divided by that corresponding
to 1% input sample (the PCR signals of this input
sample were not saturated). Bound/input values were
then averaged from multiple (at least three) PCR
reactions from independent experiments. All data in
the ﬁgures correspond to percentages of the 1% input
sample.
Invitro translations, recombinant proteins andpull-down
assays
In vitro translations and GST pull-downs were performed
essentially as described previously (31). GST and GST
fusion proteins were expressed in Escherichia coli XA90
using the pGEX (Pharmacia) vector system, for 4h
following the addition of 0.1mM IPTG at 308C.
Puriﬁcation from crude bacterial lysates was performed
as previously described (17). PGEX-HDAC1 has been
described elsewhere (17,31). The buﬀer used for the
pull-downs was a variation of Z0 (25mM HEPES
pH 7.5, 12.5mM MgCl2, 20% glycerol, 0.1% NP40,
250mM KCl).
Cellproliferation assays
Doubling time and saturation density were measured
using a modiﬁcation of a previously described method
(32). CV1 and CV1COS cells were seeded at a density
of 4 10
4 cells/60mm plate in CS (10%)-containing
DMEM. This time point was considered as day 1.
The remaining cultures were incubated with 10%
serum-containing DMEM and replenished every day.
Cells were trypsinized and counted by a hemocytometer
every day.
siRNA interference
Target sequences for small interfering RNAs (siRNS)
for HDAC1 are available upon request. The oligonucleo-
tides were cloned into a pSUPER vector (OligoEngine)
at the BglII and HindIII sites. The siRNAs were
transfected twice using Jet-Pei
TM (Polyplus-Transfection,
Illkirch, France) at 12h intervals. Target sequences for
control small interfering RNAs (c-siRNA) were as
follows: (forward) CCAGCGCTACGGCTGGCAC;
(reverse) GTGCCAGCCGTAGCGCTGG, neither of
which cross-hybridize with any human sequence.
RESULTS
Tantigen represses thetranscriptional activity ofCBP
Several independent ﬁndings indicate that SV40T antigen
represses the transcriptional activity of CBP (FL) on the
thymidine kinase (TK) promoter (11,12). On the other
hand, our previous results show that T antigen cooperates
with HAT-CBP2 to activate the hsp70 promoter (22).
This apparent discrepancy may stem from (i) the dual role
of T antigen as a promoter-dependent corepressor and
coactivator or (ii) the diﬀerential eﬀects of T antigen on
CBP (FL) and HAT-CBP2. To investigate these possibi-
lities, we ﬁrst analyzed whether T antigen represses the
transcriptional activity of HAT-CBP2 on the TK promo-
ter. To this end, transient transfections into HeLa cells
were performed using HAT and CBP2 (which contains
the T antigen interaction region) domains of CBP fused
to the Gal4 DNA-binding domain (GAL-HAT-CBP2).
The transactivation activity due to the fusion protein was
measured with a luciferase reporter vector containing ﬁve
Gal4 DNA-binding sites upstream of the TK promoter
(see Figure 1). T antigen repressed the transcriptional
activity mediated by GAL-HAT-CBP2 (Figure 1A).
Eﬃcient repression depends on the presence of the CBP2
domain (T antigen-binding region), since the transcrip-
tional activity of the GAL-HAT fusion protein lacking the
T antigen-interacting region was only slightly (19%)
repressed (Figure 1B). As previously reported, CBP (FL)
activity on the TK promoter was also repressed by T
antigen (11,12) (Figure 1C). These results indicate not
only that T antigen may work as a repressor of CBP (FL)
and HAT-CBP2, but also that it requires the T antigen-
CBP interacting domain (CBP2).
These data also suggest that T antigen may play a
dual role as a positive or negative regulator of CBP
transcriptional activity in a promoter-dependent manner.
To conﬁrm this hypothesis, we analyzed whether
T antigen acts in tandem with CBP (FL) on the
hsp70 promoter to activate transcription. Figure 1D
shows that overexpression of T antigen clearly increases
the CBP-mediated transcriptional activity on the
hsp70 promoter.
We wanted to better determine the molecular
mechanisms involved in T antigen-mediated repression.
To this end, we repeated the experiment in Figure 1A
in the presence of the histone deacetylase inhibitor
TSA. The results in Figure 2 show that the T antigen-
induced repression of HAT-CBP2 activity is partially
abolished (by 50–55%). These data suggest that
histone deacetylase activity plays a role in T antigen-
mediated repression.
Transcriptional repression of CBPby T antigencorrelates
with chromatindeacetylation
To assess whether histone deacetylation is involved in
T antigen-mediated repression, we analyzed the chromatin
acetylation status on the TK promoter using chromatin
immunoprecipitation assays (ChIPs). To this end,
HeLa cells were transfected with the TK promoter
(containing Gal 4 binding sites) and Gal-CBP in the
presence or absence of T antigen, as indicated in
Figure 3A. Cross-linked and sonicated chromatin was
immunoprecipitated using an antibody directed against
acetylated histone H3 (lysines 9 and 14) and against
acetylated histone H4 (lysines 5, 8, 12 and 16). The
precipitated DNA was analyzed by PCR with primers
1960 Nucleic Acids Research, 2007, Vol. 35, No. 6spanning the TK promoter and the luciferase coding gene
region. The resulting data were normalized relative to the
1% (unsaturated) input. The results shown in Figure 3A
and B indicate that Gal-CBP activation (lane 2) correlates
with an increase (2–3 fold) in H3 acetylation (Figure 3A
and B) as well as a slight increase in H4 acetylation
(lane 2) (Figure 3A and B). The addition of T antigen
(lane 3) leads to the clear deacetylation of both H3 and H4
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Figure 1. T antigen regulates CBP-mediated transcriptional activation. (A) HeLa cells were transfected with 2mg of the Gal4-TK-luciferase reporter,
2mg of pcDNA3-Gal-HAT-CBP2, 1 and 2mg of pSG5-T antigen or the empty vector and 1mg of renilla reporter vector. Whole cell extracts
were used in the luciferase-renilla assay. The activity derived from the Gal4-TK-luciferase reporter was normalized to 1.0 and the other activities
are expressed relative to this. The data represent an average of at least four independent transfections. (B) HeLa cells were transfected as in (A),
but the pcDNA3-Gal-HAT expression vector was used instead of pcDNA3-Gal-HAT-CBP2. (C) HeLa cells were transfected with 2mg of the
Gal4-TK-luciferase reporter, 2mg of pcDNA3-Gal-CBP (FL), 2mg of pSG5-T antigen or the empty vector and 1mg of renilla reporter vector.
Whole cell extracts were used in the luciferase-renilla assay. The transcriptional activities are expressed as in (A). The data represent an average of
at least four independent transfections. (D) HeLa cells were transfected with 2mg of the Gal4-hsp70-bgal reporter, 2mg of pcDNA3-Gal-CBP (FL),
2mg of pSG5-T antigen or the empty vector and 1mg of renilla reporter vector. Whole cell extracts were used in the b galactosidase and renilla assays.
The activity derived from the Gal4-hsp70-bgal reporter was normalized to 1.0 and the other activities are expressed relative to this. The
data represent an average of at least three independent transfections. A schematic representation of the constructs used is shown at the bottom of
each ﬁgure.
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detected in extracts subjected to immunoprecipitation with
non-speciﬁc antiserum (mock) (Figure 3A). These data
conﬁrm the previous hypothesis that histone deacetylation
acts as a mechanism involved in T antigen repression.
Finally, we wanted to test whether histone deacetylation
is involved in the T antigen-mediated repression of a
natural promoter. To this end we analyzed the chromatin
acetylation status on the PDGF b-receptor promoter.
It has been previously shown (33) that T antigen represses
this promoter in the absence of pRb and p53 in Saos-2
cells stably expressing T antigen, probably by interfering
with the transcriptional activity of Sp1, which utilizes CBP
as a coactivator. Thus, we ﬁrst tested whether histone
deacetylation was involved in T antigen-mediated repres-
sion of the PDGF b-receptor by testing the chromatin
acetylation status on this promoter in CV1 and CV1COS
cells. Figure 3C shows a clear decrease (4–5 fold) in H3 as
well as a slight decrease (2 fold) in H4 acetylation in
CV1COS compared with CV1 cells. No PCR products
were detected in extracts subjected to immunoprecipita-
tion with non-speciﬁc antiserum. These results suggest
that histone deacetylation is involved in T antigen
repression in vivo.
Tantigen interactswith Histone Deacetylase 1
(HDAC1)in vitro
Based on our previous data, we investigated whether
T antigen physically interacts with histone deacetylase
enzymes. Thus, we therefore performed in vitro pull-down
assays using 35-S-labeled T antigen. In these experiments,
diﬀerent bacterially expressed GST-HDACs (Figure 4A)
were incubated with 35-S-labeled T antigen. Reaction
mixtures were precipitated using GST-resin and the
interacting 35-S-T antigen was detected radiographically.
As shown in Figure 4B, HDAC1 clearly interacts with
T antigen in vitro. Under the same experimental condi-
tions, HDAC1 bound neither to an unrelated GST-protein
fusion (data not shown), nor to GST (Figure 4B). It has
been previously shown that T antigen interacts with
retinoblastoma products (pRb), thereby inducing cell-
cycle progression. On the other hand, several reports have
shown that pRb interacts with HDAC1 to mediate
transcriptional repression on gene promoters involved in
the G1/S phase transition of the cell cycle (34). Thus, we
decided to assess whether the T antigen-HDAC1 interac-
tion that we detected was mediated by pRb. To this end,
we repeated the previous experiments using two well-
characterized T antigen mutants that do not bind pRb (T
antigen K1 and PVU-1, see Methods). Figure 4B shows
clear T antigen K1, PVU-1 and HDAC1 interacting
signals.
We then sought to determine whether T antigen
could bridge CBP and HDAC1 cofactors. To this end,
GST-CBP was bound to 35-S-labeled T antigen using
an in vitro pull-down assay. The complex GST-CBP-T
antigen as well as the recombinant GST-CBP were
incubated with 35-S-labeled HDAC1. The reaction
mixtures were precipitated using GST-resin and the
interacting HDAC1 was detected either radiographically
or via western blot (data not shown). Figure 4C shows
that T antigen is capable of bridging CBP and HDAC1. It
is worth noting that in the absence of T antigen, GST-CBP
interacts weakly with HDAC1. However, previously
bound T antigen clearly increases this interaction,
suggesting that T antigen helps to recruit HDAC1 to the
CBP-regulated promoters.
Afterwards, we analyzed whether T antigen and
HDAC1 also interact in vivo by conducting co-immuno-
precipitation experiments using CV1COS cells, and by
two-hybrids analysis, however, no clear interaction was
observed.
HDAC1 cooperates withT antigento antagonize the
transcriptional activityof CBP
Our previous results showed that T antigen not only
represses the transcriptional activity of CBP via histone
H3 deacetylation, but that it also interacts with HDAC1
in vitro. We therefore tested the ability of HDAC1 to
cooperate with T antigen in repressing transcription and
decreasing histone H3 and H4 acetylation levels. To this
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Figure 3. T antigen repression correlates with histone H3 deacetylation. (A) HeLa cells were transfected with 2mg of Gal4-TK-luciferase reporter
(lane 1), 2mg of Gal-CBP (FL) (lane 2) and 2mg of pSG5-T antigen (lane 3) and comparative ChIP analysis were performed in parallel with the same
number of cells using antibodies that speciﬁcally recognize acetylated histone H3 (K 9 and 14) and poly-acetylated histone H4. The
immunoprecipitates were analyzed by quantitative PCR using speciﬁc primers for the TK promoter. PCR products were resolved in agarose gels and
quantiﬁed with QuantityOne software (Bio-Rad). A schematic representation of the TK-luciferase promoter and the position of the primers used for
ChIP are shown at the bottom of the ﬁgure. (B) Quantiﬁcation of PCR products from (A) was conducted as described in Materials and Methods.
The values on the y axis represent the amount of immunoprecipitated DNA as a percentage of the 1% input sample. Relative histone modiﬁcation
levels were calculated from three independent experiments. (C) Comparative ChIP analysis performed in parallel with the same number of CV1 and
CV1COS cells using antibodies that speciﬁcally recognize acetylated histone H3 (K 9 and 14) and poly-acetylated histone H4. The
immunoprecipitates were analyzed by quantitative PCR using speciﬁc primers for the PDGF b-receptor promoter. PCR products were resolved
in agarose gels and quantiﬁed as described in (B). Relative histone modiﬁcation levels were calculated from two independent experiments.
Nucleic Acids Research, 2007, Vol. 35, No. 6 1963end, transient transfections into HeLa cells were per-
formed using Gal-CBP, T antigen and the TK promoter
fused to the luciferase reporter gene (as described above)
overexpressing (or not) HDAC1. T antigen repression and
histone acetylation levels were subsequently analyzed by
luciferase and ChIPs assays, respectively. Our results
show that overexpression of HDAC1 results in increased
T antigen-induced transcriptional repression (Figure 5A),
as well as in decreased histone H3 and H4 acetylation
levels, even under basal acetylation conditions (lane 4)
(Figure 5B). This process is concomitant with HDAC1
recruitment to the promoter (lanes 3 and 4) (Figure 5B).
Only a partial transcriptional repression (24%) by
HDAC1 alone was observed (Figure 5A, lane 5),
consistently with the ability of HDAC1 to interact
weakly with CBP (see Figure 4C).
To further analyze the necessity of HDAC1 for
mediating T antigen repression in vivo, we performed
transcriptional assays (as indicated above) in the presence
of small interfering RNAs (siRNAs), which partially
block the expression of HDAC1 (HDAC1-siRNA)
following an extended expression period (Figure 5D)
and control siRNA (c-siRNA). The results in Figure 5C
show that in the presence of HDAC1 siRNA, T antigen-
mediated repression is partially reduced (from 60 to 30%).
siRNA control did not aﬀect T antigen-induced repres-
sion. The T antigen expression levels were not aﬀected by
the presence of the siRNAs (Figure 5E). Based on these
results, we would suggest that HDAC1 contributes
to T antigen-mediated repression in vivo, although we
cannot discard the participation of other deacetylases or
co-repressors in this process.
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Figure 5. HDAC1 acts in tandem with T antigen to antagonize the transcriptional activity of CBP. (A) HeLa cells were transfected with 2mg of the
Gal4-TK-luciferase reporter, 2mg of Gal-CBP (FL), 2mg of pSG5-T antigen, 1mg of pcDNA3-HDAC1 and 1mg of renilla reporter vector. Whole cell
extracts were used in the luciferase-renilla assay. The activity derived from the Gal4-TK-luciferase reporter was normalized to 1.0 and the other
activities are expressed relative to this. The data represent an average of at least ﬁve independent transfections. A schematic representation of
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bands (as described in Materials and Methods) is shown at the bottom part of the ﬁgure. (C) HeLa cells were transfected with 2mg of the
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activity derived from the Gal4-TK-luciferase reporter in the presence of the control siRNA vectors was normalized to 1.0 and the other activities are
expressed relative to this. The diagrams show the relative protein levels obtained from three independent experiments. (D) HeLa cells were transfected
with 8mg of control siRNA or diﬀerent HDAC1 siRNA (1, 2 or 3) alone or in combination. Total cells extracts were prepared 80h after transfection
and the levels of endogenous HDAC1 protein were detected by western blot analysis. The decrease of HDAC1 levels reached 90%; however, when
the HDAC1 levels were analyzed 48h after transfection the observed decrease was modest (20–30%) (data not shown). The experiment in (C) was
performed 48h after transfection due to the low activation of TK promoter by Gal-CBP after that time. (E) HeLa cells were transfected as in (A) and
the levels of T antigen protein in the presence of control siRNA or HDAC1 siRNA were analyzed by Western blot.
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stimulation of cell growth for which it requires CBP
interaction (3). As our results suggest that CBP-mediated
transcriptional activity may be repressed by T antigen, we
decided to analyze whether HDAC1 levels could aﬀect
T antigen-stimulated cell growth. To this end, CV1 and
CV1COS cells were transfected with Flag-HDAC1, or
with the vector alone. We then analyzed the doubling time
of the cells as well as Flag-HDAC1 levels over four days
after transfection. The results (Figure 6) show a clear
decrease in cell growth in CV1COS cells, suggesting that
HDAC1 levels aﬀect T antigen-induced cell growth
stimulation.
DISCUSSION
In this report, we have shown that T antigen represses
CBP-mediated transcriptional activity. This repression is
concomitant with histone H3 deacetylation and is TSA
sensitive. On the other hand, our results indicate that
T antigen interacts with HDAC1 in vitro and over-
expression of HDAC1 not only acts in tandem with
T antigen to antagonize CBP transactivation function, but
also that it correlates with chromatin deacetylation on the
TK and PDGF b-receptor promoters. Finally, decreasing
the HDAC1 levels by use of siRNAs partially abolishes
the repression induced by T antigen. The results from
these experiments are summarized in Table 1.
Our data suggest that acetylase and deacetylase
activities play key roles in the viral growth promoted by
T antigen, revealing that the latter interacts with both
HAT (11,12,22) and HDAC activities. Given that they
have opposite roles in transcriptional regulation, the
interaction of these two activities through T antigen
might appear paradoxical. However, we believe that
T antigen stimulates growth by altering gene expression
patterns; thus, the activation of one gene set might be as
necessary as the repression of another.
The possible presence of both activities in one complex
might facilitate more eﬃcient and rapid changes in
promoter acetylation. In fact, recent studies have
shown that HAT and HDAC may be found in the
same complexes. For example, HDAC1 may interact
with the HAT enzymes p300 (35) or P/CAF (36), leading
to greater control of global histone acetylation inside the
cell. Another possibility is that HAT and HDAC
reciprocally modulate their enzymatic activity or
T antigen function by cross-acetylation/deacetylation. In
this context, we must mention that T antigen exists as an
acetylated protein in vivo. p53 targets T antigen for
acetylation by CBP (2). HDAC-T antigen interaction
could favor T antigen deacetylation, thereby changing its
regulatory capabilities.
Other viral proteins have also been found to associate
with HDAC activities [E7 interacts with the Mi2-NRD
complex (28)], and in particular with the HDAC1 enzyme,
such as the adenovirus-2 E1B-55K protein (25) and the
Epstein-Barr virus nuclear antigen 3C (27). As well as
the retroviral Tax (37,38) and Tat (39–41) proteins, the
T antigen viral oncoprotein can associate with both
HDAC and HAT enzymes. This suggests that the
control of acetylation/deacetylation equilibrium is a
critical step in viral-induced cell transformation.
Our results suggest that acetylase and deacetylase
activities play key roles in the viral growth promoted by
T antigen. Indeed, our ﬁndings show that a viral
oncoprotein may manipulate gene expression by interact-
ing with both acetyltransferase and deacetylase activities.
These observations underscore the relevance of both the
acetylation/deacetylation pathways as well as chromatin
status, in cell proliferation and viral infection.
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